PX-20482-B YELLOW CHROME FREE PX-11502-B SG COLOR 9422-SCFF PX-11501-B SC SIGNAGE PLASTISOL

MONUMENT GREY B-469 HM-V3 MONUMENT GREY B-469 HM-V4 R59 NCS 0502-B WHITE

PX-30044-B DARK GREEN FILTER PLASTISOL PX-20415-B GOLD PLASTISOL PX-20441-B BLUE PUFFER PLASTISOL

SC-2300 G TAN, PART B SC-2307 G TAN, PART B SC-2318 G TAN, PART B

Newlin to Retire as CEO, Remain Executive Chairman of the Board; Robert M. CLEVELAND - PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that its Board of Directors has appointed Robert M. Patterson joined PolyOne in 2008 as senior vice president and chief financial officer, where he was responsible for global treasury, planning, M&A, accounting, internal audit functions, and investor relations.

BA B Y B OT T L E M A N U FAC T U R E R I N F A N T M I L K B O T T L E S • Compliant with FDA food contact and China National Standard GB 9685 • Able to withstand repeated steam sterilization • Transparent for more pleasing appearance and easy identification of measurement lines • Good impact resistance • Developed formulation to comply with both FDA and GB 9685 • Provided material able to withstand repeated steam sterilization and maintain excellent mechanical performance • Achieved a more pleasing color and clarity to enhance measurement lines • Met the need for impact resistance Colorant Chromatics™ PPSU Precolor KEY REQUIREMENTS WHY AVIENT?

NYSE: AVNT) AVIENT CORPORATION I N V E S T O R M E E T I N G S M A Y 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 43 Capex / Revenue 2022E (%) AV I E N T I S A S S E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 4 3 3 5 5 7 7 8 11 A vi en t A vi en t P F F U L K W R P P G R P M A V Y F M C H U N H X L E C L E M N C E A S H S C L Source: Peer data per Bloomberg market data as of April 21, 2022. Source: Peer data per Bloomberg market data as of April 21, 2022 86 82 86 86 84 78 77 89 86 81 80 76 76 76 67 67 11 (12) A vi en t A vi en t P F F U L K W R P P G R P M A V Y F M C U N V R B N R H U N H X L E C L C E A S H E M N S C L A LB 12% 18% 16% 15% 15% 14% 14% 28% 28% 26% 25% 22% 21% 19% 16% 12% 9% 9% A vi en t T od ay A vi en t P F A V Y P P G K W R FU L R P M C E A LB FM C A S H E C L E M N H X L H U N S C L B N R U N V R Median: 21%Median: 15% 2 0 2 2 E B I T DA M A RG I N S V S .

W H AT W E D O : W E A R E A F O R M UL ATO R 6 CUSTOM FORMULATION M AY 3 , 2 0 2 3 W E B C A S T Keeping Safety First o Relentless focus on best-in-class safety performance as an ACC Responsible Care® organization Exceeding Customer Expectations o Complementary technologies and customer relationships offer opportunity for future revenue synergies o Proven innovation-led commercial strategy with strong brands and participation across the full value chain Collaboration in Innovation o Leveraging Dyneema®, the world’s strongest fiber™, to accelerate growth of sustainable, ultralight and high performance applications People – Culture is Everything o Talented, passionate and collaborative associates drive an effective integration strategy o Strong Great Places to Work® scores reflect positive integration efforts in first year AVI E N T P ROT EC T I VE MAT ER I A L S I N T EG R ATI O N 8 AVI ENT PROTEC TI VE MATERI ALS K E Y I N D U S T R I E S PERSONAL PROTECTION Military • Law Enforcement • First Responders • Body Armor • Helmets • Vehicle Protection 50% MARINE & SUSTAINABLE INFRASTRUCTURE Towing / Mooring • Aquaculture • Floating Wind • Offshore Cranes 30% CONSUMER Consumer • Outdoor High Performance • Safety Equipment 20% 9 Figures reflect approximate proportions of 2022 sales Q 1 P E R F O R M A N C E Q1 2023 PERFORMANCE VS. GUIDANCE ( T O TA L C O M PA N Y ) 11 $845 $846 Guidance Actual $125 $134 Guidance Actual Sales Adjusted EBITDA (in millions) $0.55 $0.63 Guidance Actual Adjusted EPS (in millions) Q1 2023 PERFORMANCE VS. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 37 79 89 83 81 76 73 90 82 77 76 74 70 58 22 A vi e n t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of May 31, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $36.50.

D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of February 15, 2022 86 89 85 80 76 76 89 85 79 78 76 76 76 70 69 63 8 A vi e n t K W R P P G F U L A V Y R P M F M C U N V R H U N B N R H X L E C L C E A S H E M N S C L A L B Source: Peer data per Bloomberg market data as of February 15, 2022 Total Enterprise Value / 2022E EBITDAWith the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

W H AT W E D O : M AT E R I A L S C I E N C E 5 CUSTOM FORMULATION F E B R U A R Y 1 5 , 2 0 2 3 W E B C A S T Q4 2022 VS. GUIDANCE ( T O TA L C O M PA N Y P R O F O R M A ) 7 $100 $107 Guidance Pro Forma $0.33 $0.42 Guidance Pro Forma Adjusted EBITDA Adjusted EPS (in millions) $200 $293 Guidance Actual Free Cash Flow (in millions) FY 2022 VS. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 31 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi e n t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.